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The T3 molecule on the surface membrane of T lymphocytes is involved in the transduction of the prolifera- 
tion signal generated by an interaction between the antigen receptor and an antigen, to the interior of the 
T cell. Mitogenic monoclonal antibodies against the T3 molecule and mitogenic lectins induce a rapid (with- 
in 5 min) protein synthesis-independent activation of ornithine decarboxylase (ODC) in human T lympho- 
cytes. When T cells are selectively depleted of guanine nucleotides by treatment with mycophenolic acid, 
the early mitogen-induced activation of ODC is completely inhibited. The inhibition rapidly reverted on 
the addition of guanine a few minutes before the mitogenic stimulation, and even more rapidly by GTP 
directly introduced into the T cells by a transient membrane permeabilization. GTP can be substituted for 
by a non-hydrolyzable GTP analogue, GTP-y-S, which also induces ODC activity by itself in human T cells. 
These results suggest hat a G-protein(s) is involved in the transduction of the proliferation signal in human 
T cells. 
G-protein; Ornithine decarboxylase; Signal transduction; Lymphocyte transformation 
1. INTRODUCTION 
One of the earliest detectable events in T lym- 
phocytes stimulated to proliferate by mitogenic 
monoclonal antibodies or lectins, is a severalfold 
elevation in the activity of ornithine decarboxylase 
(ODC) within minutes [l-4]. Non-mitogenic 
ligands to T lymphocytes do not induce ODC ac- 
tivation. The rapid induction of ODC activity by 
mitogens is independent of de novo protein syn- 
thesis but requires energy and an intact 
cytoskeleton [ 11. Earlier we have shown this rapid 
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enzyme activation to be associated with the 
mitogen-stimulated breakdown of phosphoinosi- 
tides [3]. In many different cells the ligand-induced 
enhancement of the turnover of phosphoinositides 
is mediated by guanine nucleotide binding re- 
gulatory proteins, G-proteins [4,5]. Thus it is 
possible that the early activation of ODC is 
regulated by a G-protein. 
The G-proteins, including the ras proto- 
oncogene encoded proteins, are small proteins on 
the cytoplasmic surface of the plasma membrane. 
These are involved in the transduction and regula- 
tion of various signals from the external milieu 
[5-81. The G-proteins bind guanine nucleotides 
and display high-affinity GTPase activity [9, lo]. 
The G-proteins are functionally active when GTP 
is bound. Their function is terminated when the 
bound GTP is hydrolyzed [6,7,11]. Accordingly, 
treatment with non-hydrolyzable GTP analogues 
retains G-proteins in a functional state 
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[5-l% f 2-141, as do point mutatjuns leading to 
decreased GTPase activity [15,i6]. Depletion of 
the cellular pool of GTP has, on the other hand, 
been shown to impair the signal transducing 
capacity of G-proteins 1171. 
My~oph~~~li~ acid produced by ~~~~c~~~~~~ 
~~u~o~~~~~ is a potent ~~~ib~tor f guanine 
nucleotide synthesis in mammalian cells f lg-20J. 
MyAc profoundly inhibits the enzyme inosine 
monophosphate dehydrogenase which produces 
the guanine nucleotide precursor xanthosine 
monophosphate* but does not interfere with the 
synthesis of other nu~leotid~s f203. Treatment of 
cells with MyAc has been shown to lower the 
cellular GTP content to 10-20010 [17,20]. A pool 
of GTP with rapid turnover is apparently soon ex- 
hausted, while a pool of more tightly bound GTP 
is relatively spared. Thus, the RNA and, protein 
synthesis rem&ins intact for several hours in cells 
treated with MyAc [20]. 
2. MATERIALS AND METHODS 
Ficoll-Isopaque was from Pharmacia (Sweden), 
mycophenolic acid from Sigma (FRG), all 
nucleotides from Boehringer Mannheim (FRG) 
and the radioactive compounds from Amersham 
knead). 
2.2. Ceiis 
Buffy coats of blood units were kindly provided 
by the Finish Red Cross Blood Transfusion Ser- 
vice, The mononuclear leukocytes were isolated by 
~entrifuga~o~ on ~~ll~~so~a~ue_ The T lym- 
phocytes were further enriched by passage through 
nylon wool columns [21]. 
The T l~ph~~ were incubated for 2 h at 
37°C in RPM1 1640 medium in the presence of 
mycophenolic acid (MyAc) to deplete the cells of 
guanine nucleotides. In experiments where the 
reversal by guanine, GTP or GTP~-S was examin- 
ed, the cells were always preincubated for 2 h in 
1~~~ MyAc, prior to ~rrn~~~~~o~ and/or 
stimulation. Xn these experiments the concentra- 
tion of MyAc was kept at lOO/rM at all stages. 
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The membranes of T lymphocytes were tran- 
siently made permeable for small compounds such 
as GTP and GTP-1/-S, by the ATP4- method as 
described by Gomperts and co-workers I&22]. 
Earlier we have reported the application of this 
method to T l~p~o~yt~ f4]_ 
2.5. ODC assay 
The activity of GDC was measured by the libera- 
tion of “CO~ from j[l-14C]ornithine as described 
I23], in the su~~~~~t of cell samples disrupted 
by so~~ation and cleared by ~~~t~ifugation for
45 min at 42000 x g, 
2.6, Mcrasurement of RNA and protein synthesis 
The incorporation of 13H]uridine and f%lleu- 
tine during a 3 h incubation into ~ri~hloro~eti~ 
~~id~~r~ipitable material was measured from 
samples of 1 x l$ cells, cultured in RPM1 1640 
medium at 37°C and harvested by a multichannel 
cell harvester (Scatron, Norway) after the addition 
of 1 / 10 vol. trichloroacetic acid. The radioactivity 
was counted in ACS s~i~t~ation fluid (Amersh~~ 
England), 
3. RESULTS 
When human T ~yrn~~~c~es were incubated in 
the presence of 100 pM MyAc for 2 h, the activa- 
tion of UDC normally seen within 10 min after 
treatment with a mitogenic ligand (the monoclonal 
antibody 0KT3 or ConA) was abolished. This ef- 
fect of MyAc was dose-dependent (f&l). The in- 
hibition was rapidly reversed in a dose-dependent 
fashion by Janice (fig.2)), added a few minutes 
before the mitogenic stimulatia~ (fig.3). The 
results from experiments using the monoclonal an- 
tibody 0KT3 are shown in table 1, Guanosine also 
reverted the MyAc-induced inhibition of ODC ac- 
tivation, while all other compounds tested 
(ade~osi~e~ erosive, uridine, t~~i~ne) were 
without effects (not shown). Treatment of resting 
or mitogen-stimulated T lymphocytes with guanine 
alone did not alter their ODC activities (not 
shown). 
To further demonstrate the specific requirement 
for GTP in the a~~is~t~on of ODC by mitogens, ex- 
ogenous GTP was introduced directly into MyAc- 
treated, transiently membrane permeabilized T 
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Fig.1. The effects of MyAc on the inducibility of ODC 
activity by ConA (0) and in unstimulated cells (0). The 
cells were preincubated for 2 h in the presence of the 
indicated concentrations of MyAc before ConA 
(lOpg/ml) was added. The activity of ODC was 
measured 10 min later and is expressed as pmol 14C02/h 
per lo6 cells. 
*L 
concentration, JAM 
Unstimulated cells 18.1 + 3.4 
Cells treated with 0KT3 (10 min) 59.0 Zt 5.7 
MyAc-treated cells i- 0KT3 (IO min) 13.3 * 3.3 
MyAc-treated cells + guanine 
(lOOpM, IO min) + 0KT3 
(10 min) 66.5 f 7.5 
Fig.2. Dose-dependent reversal of the MyAc-induced The cells were preincubated for 2 h in 100 pM MyAc and 
inhibition of ODC activation by guanine. The cells were 10 min after the addition of 100~M guanine prior to 
preincubated for 2 h in 100 FM MyAc and then 10 min stimulation with 25 nglml OKT3. The activity of ODC 
in the presence of the indicated concentrations of was measured 10 min later and is expressed as pm01 
guanine (MyAc still present). The activity of ODC was 14C02/h per IO6 cells; the data represent means f SD, 
measured as in fig. 1. from three experiments 
lymphocytes. In these cells the ODC activation was 
fuily inducible immediateIy after the permeabiliza- 
tion step (fig.4). Approx. 5 pM GTP was needed 
for 50% reversal. The introduced GTP did not by 
~~ 60 90 120 150 
PhnoUbatiion time, min 
Fig.3. Time course of the MyAc-induced inhibition of 
the activation of ODC and reversal of the inhibition by 
addition of 1OOpM guanine. The activity of ODC was 
measured after 10 min in the presence (e) or absence 
(0) of ConA, as in fig.1. 
Table 1 
The effects of MyAc and guanine on the activation of 
ODC by a monoclonal antibody against the T3 molecule 
(OKT3) 
Ornithine 
decarboxylase 
activity (pm01 
r4COz/h per IO6 
cells) 
itself activate ODC. When GTP-y-S was intro- 
duced into Ryan-treated celk, an activation of 
ODC was observed after the addition of ConA 
(fig.4). ATP or the non-hydrolyzable GDP 
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c~ion, MM 
Fig.4. Reversai of the MyAc-induced inhibition of ODC 
activation by GTP (a,~), GTP-$5 (A), GDP-&S (w) 
and ATP (T). The cells were preincubated for 2 h in 
IOOpM MyAc, permeabilized in the presence of 
indicated nucleotides, resealed and treated with (filled 
symbols) or without (open symbols) ConA (10 pg/ml) 
for 10 min, as in fig.1. 
Table 2 
RNA and protein synthesis in human T cells pretreated 
with 1OOpM MyAc and 100,uM guanine for 2 h’ 
Incorporation of 
r3H]Leucine ~3H~Uridine 
(cpm/106 cells) 
Untreated cells 
MyAc-treated cells 
MyAc-treated cells + 
6577 +_ 785 1085 tf: 404 
6124 f 452 1156 + 240 
guanine 100 pM 6510 Z!I 632 1492 f 129 
Cycloheximide-treated cells 4391 JL: 525 not done 
Cycloheximide (20pg/ml) treated cells were used as 
controls 
analogue GDP-,&S could not replace GTP (fig.41 
and all other nucleotides tested (ATP-y-S and 
dTTP) were also ineffective (not shown). 
To exclude the possibility that the MyAc- 
induced inhibition of ODC activation was caused 
by significantly decreased protein or RNA syn- 
thesis during the preincubation in MyAc, incor- 
poration of radiolabeled leucine and uridine into 
trichloroacetic acid-precipitable material was 
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measured. In cells treated with MyAc for 5 h, the 
incorporation of these compounds during the last 
3 h was only slightly decreased. In the presence of 
guanine this small decrease was absent (table 2). 
4. DISCUSSION 
Mature T cells express an idiotypic antigen 
receptor on their surface. When this receptor binds 
its specific antigen the T cell undergoes blast- 
transformation and starts to proliferate. Since the 
receptor polypeptides only have a few amino acids 
inside the plasma membrane, it is generally 
thought that the tightly associated T3 molecule is 
responsible for transducing the activation signal 
from the antigen receptor to the inside of the T 
cell. The mechanism and immediate target of this 
mitogenic signal transduction are, however, 
unknown. 
The presented results indicate that GTP is need- 
ed for the rapid activation of ODC in human T 
lymphocytes by an antibody against the T3 
molecule (OKT3) or the lectin ConA. This is the 
first demonstration of the involvement of a G- 
protein in the transduction of the proliferation 
signal from the antigen receptor-T3 complex. We 
have demonstrated earlier that non-hydrolyzable 
GTP analogues (without addition of mitogens) in- 
duce a rapid ODC activation, suggesting the par- 
ticipation of a G-protein 143, but it has not until 
now been clear which receptor is linked to this G- 
protein. 
Pertussis and cholera toxins have been widely 
used in the studies of G-proteins. Unfortunately 
these toxins do not affect the ras encoded ~21s. On 
the other hand, a selective depletion of the cellular 
pool of guanine nucleotides by treatment with 
MyAc apparently affects all G-proteins, including 
the ~21s. The rapid reversal by guanine, guanosine 
or GTP further emphasizes the usefulness of 
MyAc in the studies of G-protein mediated events 
in whole cells. 
Of the hitherto identified G-proteins, only the 
ras-proto-oncogene ncoded proteins (~21) have 
clearly been implicated in the regulation of pro- 
liferation [24-281. Several recent reports indicate 
that r~s encoded proteins may be involved in the 
regulation of phosphatidylinositol turnover 
[29-311. Sistonen et al. [32] have shown that 
transfection of fibroblasts with the Ha-ras 
Volume 213, number 1 FEBS LETTERS March 1987 
(mutated in codon 12) leads to high and dose- 
dependent ODC activities in the cells. Further- 
more, the early ODC activation obtained with 
mitogenic ligands in human T cells is insensitive to 
pretreatment of the cells with either pertussis or 
cholera toxins (unpublished). Therefore it seems 
possible that the G-protein involved in the activa- 
tion of ODC (by stimulating phosphatidylinositol 
breakdown) during the onset of proliferation of 
human T lymphocytes is in fact a c-ras-encoded 
p21. 
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